(EPD) Enterprise Products Partners - Overview
Stock: NGL, Crude, Gas, Petrochemical
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.98% |
| Yield on Cost 5y | 15.05% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 99.0% |
| Payout Ratio | 81.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.8% |
| Relative Tail Risk | 3.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.19 |
| Alpha | -2.05 |
| Character TTM | |
|---|---|
| Beta | 0.431 |
| Beta Downside | 0.688 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.40% |
| CAGR/Max DD | 1.10 |
Description: EPD Enterprise Products Partners January 29, 2026
Enterprise Products Partners L.P. (NYSE: EPD) is a U.S.-based midstream operator that moves, stores, and processes natural gas, NGLs, crude oil, refined products, and petrochemicals. Its business is organized into four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services.
In the most recent quarter (Q4 2024), EPD reported adjusted EBITDA of **$2.3 billion** and total revenue of **$13.5 billion**, reflecting a 6 % YoY increase driven largely by higher NGL processing volumes and stronger fee-based contracts. Utilization rates across its core pipelines are near historic highs-**85 %** for NGL pipelines and **78 %** for natural-gas pipelines-while underground salt-dome storage inventories sit at roughly **70 %** of capacity, indicating ample headroom for seasonal demand spikes.
Key economic drivers for the company include: (1) the widening **NGL price spread** (NGLs trading ~ $2.10 per MMBtu above Henry Hub in early 2025), which boosts processing margins; (2) **crude-oil price volatility**, which underpins demand for EPD’s flexible storage and truck-fleet services; and (3) sustained growth in **U.S. petrochemical demand**, especially for propylene and isobutylene, supporting the utilization of its dehydrogenation and fractionation assets. The broader midstream sector is operating at an average **78 % capacity utilization** (S&P Global, 2025), a level that historically correlates with higher fee-based earnings for diversified operators like EPD.
For a deeper, data-rich view of how these fundamentals translate into valuation metrics, a quick look at ValueRay’s analyst toolkit can help you spot any pricing gaps.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 5.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.86 > 1.0 |
| NWC/Revenue: -3.42% < 20% (prev 1.73%; Δ -5.15% < -1%) |
| CFO/TA 0.11 > 3% & CFO 8.47b > Net Income 5.79b |
| Net Debt (33.37b) to EBITDA (9.69b): 3.45 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -0.27% < -2% |
| Gross Margin: 13.37% > 18% (prev 0.13%; Δ 1325 % > 0.5%) |
| Asset Turnover: 69.34% > 50% (prev 75.46%; Δ -6.12% > 0%) |
| Interest Coverage Ratio: 5.28 > 6 (EBITDA TTM 9.69b / Interest Expense TTM 1.37b) |
Beneish M -3.17
| DSRI: 0.98 (Receivables 7.51b/8.20b, Revenue 53.00b/56.64b) |
| GMI: 0.94 (GM 13.37% / 12.63%) |
| AQI: 1.00 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 0.94 (Revenue 53.00b / 56.64b) |
| TATA: -0.03 (NI 5.79b - CFO 8.47b) / TA 77.82b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of EPD shares?
Over the past week, the price has changed by +2.07%, over one month by +4.89%, over three months by +10.39% and over the past year by +7.30%.
Is EPD a buy, sell or hold?
- StrongBuy: 9
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.6 | 7.1% |
| Analysts Target Price | 35.6 | 7.1% |
| ValueRay Target Price | 40 | 20.5% |
EPD Fundamental Data Overview January 30, 2026
P/E Forward = 11.6009
P/S = 1.3669
P/B = 2.4567
P/EG = 2.3242
Revenue TTM = 53.00b USD
EBIT TTM = 7.26b USD
EBITDA TTM = 9.69b USD
Long Term Debt = 31.11b USD (from longTermDebt, last quarter)
Short Term Debt = 2.46b USD (from shortTermDebt, last quarter)
Debt = 33.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.37b USD (from netDebt column, last quarter)
Enterprise Value = 105.82b USD (72.45b + Debt 33.58b - CCE 206.0m)
Interest Coverage Ratio = 5.28 (Ebit TTM 7.26b / Interest Expense TTM 1.37b)
EV/FCF = 34.21x (Enterprise Value 105.82b / FCF TTM 3.09b)
FCF Yield = 2.92% (FCF TTM 3.09b / Enterprise Value 105.82b)
FCF Margin = 5.84% (FCF TTM 3.09b / Revenue TTM 53.00b)
Net Margin = 10.93% (Net Income TTM 5.79b / Revenue TTM 53.00b)
Gross Margin = 13.37% ((Revenue TTM 53.00b - Cost of Revenue TTM 45.91b) / Revenue TTM)
Gross Margin QoQ = 13.78% (prev 15.59%)
Tobins Q-Ratio = 1.36 (Enterprise Value 105.82b / Total Assets 77.82b)
Interest Expense / Debt = 1.05% (Interest Expense 354.0m / Debt 33.58b)
Taxrate = 1.08% (65.0m / 6.04b)
NOPAT = 7.18b (EBIT 7.26b * (1 - 1.08%))
Current Ratio = 0.88 (Total Current Assets 13.24b / Total Current Liabilities 15.05b)
Debt / Equity = 1.15 (Debt 33.58b / totalStockholderEquity, last quarter 29.21b)
Debt / EBITDA = 3.45 (Net Debt 33.37b / EBITDA 9.69b)
Debt / FCF = 10.79 (Net Debt 33.37b / FCF TTM 3.09b)
Total Stockholder Equity = 28.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.58% (Net Income 5.79b / Total Assets 77.82b)
RoE = 19.99% (Net Income TTM 5.79b / Total Stockholder Equity 28.98b)
RoCE = 12.08% (EBIT 7.26b / Capital Employed (Equity 28.98b + L.T.Debt 31.11b))
RoIC = 11.69% (NOPAT 7.18b / Invested Capital 61.43b)
WACC = 5.46% (E(72.45b)/V(106.03b) * Re(7.50%) + D(33.58b)/V(106.03b) * Rd(1.05%) * (1-Tc(0.01)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.14%
[DCF Debug] Terminal Value 84.77% ; FCFF base≈3.31b ; Y1≈2.86b ; Y5≈2.28b
Fair Price DCF = 16.55 (EV 69.17b - Net Debt 33.37b = Equity 35.79b / Shares 2.16b; r=5.90% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 55.68 | EPS CAGR: 8.29% | SUE: -0.58 | # QB: 0
Revenue Correlation: -2.70 | Revenue CAGR: 1.50% | SUE: 0.16 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.67 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.85 | Chg30d=-0.015 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+2.1%